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The MiDAC histone deacetylase complex is
essential for embryonic development and has a
unique multivalent structure
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MiDAC is one of seven distinct, large multi-protein complexes that recruit class I histone
deacetylases to the genome to regulate gene expression. Despite implications of involvement
in cell cycle regulation and in several cancers, surprisingly little is known about the function or
structure of MiDAC. Here we show that MiDAC is important for chromosome alignment
during mitosis in cancer cell lines. Mice lacking the MiDAC proteins, DNTTIP1 or MIDEAS,
die with identical phenotypes during late embryogenesis due to perturbations in gene
expression that result in heart malformation and haematopoietic failure. This suggests that
MiDAC has an essential and unique function that cannot be compensated by other HDAC
complexes. Consistent with this, the cryoEM structure of MiDAC reveals a unique and
distinctive mode of assembly. Four copies of HDAC1 are positioned at the periphery with
outward-facing active sites suggesting that the complex may target multiple nucleosomes
implying a processive deacetylase function.
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C lass I histone deacetylases (HDACs 1–3) are essentialregulators of gene expression. The enzymes are recruitedto chromatin as part of large multi-protein complexes that
control the acetylation state of histones and other chromatin-
associated factors. These are high stoichiometry acetylation sites
whose regulation controls gene transcription1.
In addition to the HDAC catalytic subunit, these complexes
contain scaffold proteins that mediate interaction with tran-
scription factors and chromatin, thereby determining the speci-
ficity of these complexes. Importantly, class I HDACs have
enhanced catalytic activity when assembled into their cognate
complexes and their activity is further increased by binding
higher order inositol phosphates2,3. Inhibitors of class I HDACs
have been used to target a number of diseases, including HIV,
Alzheimer’s disease and cancer4–7.
The best-studied complexes include the NuRD, Sin3 and
CoREST complexes which contain HDAC1/2, and the SMRT/
NCoR complex that contains HDAC38–11. The MiDAC complex,
the focus of this study, is relatively poorly understood. The
complex contains three proteins: HDAC1/2, MIDEAS (aka.
ELMSAN1, c14orf43) and DNTTIP1 (aka. TDIF1). It was first
identified through chemoproteomic approaches. The complex
was recruited to an HDAC-inhibitor-bound resin in cells stalled
in mitosis by nocodazole treatment—hence the name mitotic
deacetylase complex (MiDAC)12. Subsequent proteomic studies
supported the identification of the MiDAC complex13–16. The
complex is present in diverse species such as nematodes and jelly
fish, suggesting that it plays an important role that has been
conserved through evolution. Further evidence that the MiDAC
complex has a role in the cell cycle comes from the observation
that MiDAC components are associated with, and are substrates
of, the CyclinA2/CDK2 complex17.
Consistent with a role in cell proliferation, components of the
MiDAC complex have been implicated in a number of human
cancers. DNTTIP1 has a critical role in oral cancer and is pro-
posed to be oncogenic in non-small cell lung cancers18,19. A
number of large-scale cancer genome studies have associated
downregulation of MIDEAS with cutaneous melanoma; MIDEAS
as a mutational hotspot and potentially a rare tumour gene20–22.
The evolutionary conservation of MiDAC, together with
apparent roles in the cell cycle and in several cancers suggests that
MiDAC is an important deacetylase complex. In this study, to
gain a better understanding of MiDAC’s biological role, we
explore the effects of depleting MiDAC in cells and mice. Cell-
based assays show that the endogenous complex is present
throughout the cell cycle, but that siRNA knockdown of either
DNTTIP1 or MIDEAS results in increased metaphase chromo-
some misalignment. Homozygous mice embryos lacking either
MIDEAS or DNTTIP1 die after day e16.5 with identical pheno-
types. The embryos are severely anaemic and have a clear mal-
formation of the heart. Gene expression analyses in fibroblasts
derived from the homozygous embryos show a significant overlap
in the gene sets whose expression is perturbed, many of which are
involved in developmental pathways.
To understand how the MiDAC complex is assembled and
how it is distinct from other HDAC complexes, we use cryo-EM
to determine the structure of the complex. Unexpectedly, the
ELM2 domain of MIDEAS mediates dimerisation through
interaction with DNTTIP1. The MIDEAS-SANT domain med-
iates tetramerisation of the complex. The overall assembly of the
complex is critically dependent on the interactions between
DNTTIP1 and MIDEAS. The tetrameric architecture resembles a
three-dimensional X-shape with the HDAC catalytic sites at the
four extremities of the complex, suggesting that the complex is
able to simultaneously target multiple nucleosomes and that it
might therefore be a highly processive deacetylase complex. Both
the knockout mice and the cryo-EM structure are consistent with
co-dependency of DNTTIP1 and MIDEAS for both the structure
and function of the MiDAC complex. These data provide an
important step change in our understanding of the mammalian
MiDAC complex.
Results
MIDEAS, DNTTIP1 and HDAC1 co-localise through the cell
cycle. To investigate the sub-cellular distribution of MIDEAS,
DNTTIP1 and HDAC1, we used immunofluorescence in human
U2OS cells. Antibodies were selected based on the epitope being
both unique and characterised for specificity using GFP-MIDEAS
and mCherry-DNTTIP1 (see below and Supplementary
Fig. 1a–d).
HDAC1, MIDEAS and DNTTIP1 are located predominantly in
the soluble nuclear fraction in U2OS cells (Fig. 1a). Moreover,
immunoprecipitation with antibodies against MIDEAS or
DNTTIP1 showed HDAC activity significantly greater than in a
control IP (Fig. 1b). This activity was blocked by the HDAC
inhibitor SAHA and potentiated by inositol hexakispho-
sphate (InsP6) (Fig. 1c).
Previously, Bantscheff et al.12 reported that an HDAC-
inhibitor matrix preferentially pulls down DNTTIP1 in cells
blocked in the mitosis by nocodazole. To explore whether this is
explained by variation in expression through the cell cycle or
changes in localisation, we used immunofluorescence microscopy
with HDAC1, MIDEAS and DNTTIP1 antibodies to visualise the
endogenous proteins at multiple cell-cycle stages (Fig. 1d).
HDAC1, MIDEAS and DNTTIP1 showed nuclear localisation
throughout interphase, but started to become excluded from
chromatin as chromosomes condensed during early mitosis
(prophase). The proteins were then recruited back into nuclei as
they re-formed and the chromatin decondensed during late
mitosis (telophase) (Fig. 1d).
To explore this further, we used CRISPR/Cas9-mediated gene
editing to introduce a FLAG epitope onto the C-terminus of the
endogenous MIDEAS protein in mouse embryonic stem (ES) cells
(Supplementary Fig. 1e, f). Western blotting confirmed that both
MIDEAS and DNTTIP1 are present at all stages of the cell cycle
(Fig. 1e; Supplementary Fig. 2a) and that MIDEAS-FLAG pulled-
down DNTTIP1 throughout the cell cycle (Fig. 1f; Supplementary
Fig. 2b). Furthermore, in U2OS cells, antibodies against MIDEAS
and DNTTIP1 were able to co-immunoprecipitate the other
protein as well as both HDACs 1 and 2 in asynchronous cells and
cells in both G1/S and M phase (Fig. 1g; Supplementary Fig. 2c).
The HDAC activity of immunoprecipitated complexes from G1/S
cells showed slightly higher activity than either asynchronous or
mitotic cells (Fig. 1h; Supplementary Fig. 2c).
MIDEAS and DNTTIP1 protein expression is co-dependent.
To investigate the role of the MiDAC complex in U2OS cells, we
obtained two independent siRNAs against both MIDEAS and
DNTTIP1 (two against each transcript). Both MIDEAS siRNAs
significantly reduced MIDEAS mRNA expression relative to
control. Similarly, siRNAs directed against DNTTIP1 effectively
abolished DNTTIP1 mRNA expression (Supplementary Fig. 3a,
b). Each siRNA was specific to its target, and there was no effect
on the mRNA expression level of the other components of the
complex (Supplementary Fig. 3a–c). Western blotting using the
soluble nuclear fraction from cells treated with siRNAs against
both DNTTIP1 and MIDEAS showed significantly reduced pro-
tein levels for both MIDEAS and DNTTIP1, but not HDAC1
(Fig. 2a; Supplementary Fig. 3d). These results suggest that pro-
tein expression and stability of MIDEAS and DNTTIP1 are
mutually co-dependent whilst that of HDAC1, probably due to its
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participation in other complexes, is unaffected. This observation
that DNTTIP1 and MIDEAS protein levels are co-dependent in
cells fits well with the architecture of the MiDAC complex (see
below).
MiDAC depletion increases mitotic chromosome misalign-
ment. siRNA knockdown of either MIDEAS or DNTTIP1 in
asynchronous U2OS cells, resulted in a significant increase in
misaligned chromosomes during metaphase. Figure 2b shows
representative images of control and siRNA-treated metaphase
cells. The misalignment in cells with reduced MIDEAS and
DNTTIP1 correlates with aberrant DNA and CENPA staining
away from the metaphase plate. Quantification of this observation
showed that both MIDEAS and DNTTIP1 siRNA’s increased
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misalignment by 1.5-fold and twofold, respectively, compared
with control transfections (Fig. 2c). To check this result was not
specific to U2OS cells, we also performed siRNA-mediated
knockdown of MIDEAS in HeLa cells and observed a similar
increase in chromosome misalignment (Fig. 2d).
To confirm that the misalignment phenotype is due to loss of
the MiDAC complex and not off-target effects of the siRNAs, we
created a stable U2OS cell line with a doxycycline-inducible
siRNA-resistant FLAG-DNTTIP1. Western blotting confirmed
that the FLAG epitope could only be detected in the presence of
doxycycline (Fig. 2e). Addition of DNTTIP1 siRNA decreased
endogenous DNTTIP1 protein levels regardless of whether
doxycycline was present or not, but had no effect on the
expression of the siRNA-resistant FLAG-DNTTIP1 (Fig. 2e;
Supplementary Fig. 3e–g). Both siRNAs against DNTTIP1
increased chromosome misalignment in the absence of doxycy-
cline as seen previously. As expected, induction of FLAG-
DNTTIP1 with doxycycline reduced misalignment to a level
comparable with control transfections (Fig. 2f).
MiDAC plays an essential role in late embryogenesis. To
explore the role of the MiDAC complex in vivo, we used CRISPR-
Cas9-mediated gene editing to generate KO alleles for both
Mideas and Dnttip1. crRNAs targeting exon 2 of either Mideas
and Dnttip1 were injected into single-cell zygotes to generate 10-
bp and 11-bp deletions, respectively. These modified alleles pro-
duce a premature stop codon within the open-reading frames of
both genes leading to a constitutive KO phenotype (Supple-
mentary Fig. 4). Heterozygous mice were healthy and fertile and
so were inter-crossed to generate homozygous animals. Geno-
typing the resulting litters revealed a complete absence of viable
homozygous pups from both MIDEAS-del1 and DNTTIP1-del1
heterozygous crosses, indicating an essential role for the MiDAC
complex during embryogenesis (Supplementary Table 1).
To investigate the stage at which the homozygous embryos die,
we performed a series of timed matings. We observed homo-
zygous embryos at days e13.5, e14.5, e15.5 and e16.5. Strikingly,
the homozygous embryos are readily identified through their pale
colour and somewhat smaller size than the wild-type or
heterozygous embryos (Fig. 3a; Supplementary Fig. 5a, b).
Stained sections of the homozygous embryos showed a
remarkable lack of red blood cells in the heart and vessels
throughout the body, as well as morphological differences in the
heart itself (Fig. 3b; Supplementary Fig. 5c, d). The heart is
smaller and malformed with an enlarged pericardium. The lack of
blood would suggest either a failure of haematopoiesis; substantial
vascular leakage or perhaps abnormally rapid turnover of blood
cells. The spleen and liver are the main sites of haematopoiesis at
this stage of development. However, these tissues in the mutant
animals appear to be morphologically normal with comparable
numbers of hematopoietic precursors (Supplementary Fig. 5d).
MiDAC knockout perturbs multiple gene-regulatory networks.
To determine the gene-regulatory consequences of the MIDEAS
and DNTTIP1 deletions, we prepared mouse embryonic fibro-
blasts (MEFs) from day e13.5 embryos. Wild-type (+/+) and
homozygous (−/−) lines were established from the MIDEAS-
del1 and DNTTIP1-del1 embryos. Successful gene deletions were
confirmed by genotyping and loss of HDAC activity in a co-IP
assay or loss of protein by western blot analysis (Supplementary
Fig. 6a–d). Interestingly, for both gene deletions, there was no
apparent defect in cell proliferation or cell-cycle progression,
consistent with the observed late developmental failure (Supple-
mentary Fig. 6e–h). Importantly, however, we observed a sig-
nificant increase in chromosome misalignment during metaphase
in both MIDEAS−/− and DNTTIP1-del1−/− MEFs (Fig. 3c).
To further investigate the possible mechanisms for increased
chromosome misalignment, heart malformation and likely hae-
matopoietic failure, the total RNA was isolated from wild-type,
MIDEAS−/− and DNTTIP1−/− MEF lines and used for RNAseq
analysis. In total, 468 differentially expressed transcripts were
common to both the MIDEAS and DNTTIP1 knockouts (Fig. 3d)
with more transcripts showing increased than decreased expression
(Fig. 3e). The changes in the common transcripts showed a
clear correlation (R2= 0.91) in both direction and magnitude
of altered expression in MIDEAS−/− and DNTTIP1−/− cells,
again confirming the co-dependence of MIDEAS and DNTTIP1
(Fig. 3f).
DAVID23 and Panther24 pathway analyses indicate that the set
of overlapping, upregulated genes from the knockout cell lines are
enriched in genes involved in developmental pathways, in
particular Wnt signalling, Cadherin signalling and axon guidance.
Other pathways affected include FGF and EGF signalling and
angiogenesis (Fig. 3g; Supplementary Fig. 5e and Supplementary
Table 2). Interestingly, analysis based on tissue specificity suggests
that many of these genes are involved in brain development
(Fig. 3h). Normally, these genes would not be expected to be
expressed in fibroblasts. It is likely that one of the roles of the
MiDAC complex is to repress expression of these genes.
Gene ontology analysis also identified some genes involved in
cell-cycle regulation (Supplementary Table 3), and gene set
enrichment analysis (GSEA; Broad Institute25) showed that there
Fig. 1 Nuclear localisation and HDAC activity of the endogenous MiDAC complex. a Cytoplasmic and nuclear proteins were prepared from U2OS cells
before western blotting using antibodies against MIDEAS, DNTTIP1 and HDAC1. Antibodies against GAPDH and LaminB were used, respectively, as
cytoplasmic and nuclear housekeeping controls. b Fluorescent-based HDAC activity assay of IgG control, MIDEAS and DNTTIP1 immunoprecipitates from
U2OS nuclear lysates (mean ± s.e.m, n= 8 independent experiments, ***P= 0.001, **P= 0.0012, one-way ANOVA with Holm–Sidak post hoc test).
c Fluorescent- based HDAC activity assay of MIDEAS and DNTTIP1 immunoprecipitates from nuclear lysates that had been pre-incubated with 100 μM
InsP6 or 5 μM SAHA for 30min. IgG controls were performed in parallel and used to subtract background activity before normalisation to untreated
complex HDAC activity (mean ± s.e.m, n= 4 independent experiments, ****P < 0.0001, one-way ANOVA with Holm–Sidak post hoc test). d Confocal
images of PFA fixed U2OS cells dual stained with either HDAC1 (grey), MIDEAS (green) or DNTTIP1 (yellow) antibodies and anti-α-tubulin (magenta).
DNA (blue) was visualised with Hoechst 33258 (scale bars: interphase, 10 μm; mitotic cells, 5 μm). e Western blot for DNTTIP1, MIDEAS-FLAG and
Tubulin using lysates from MIDEAS-FLAG CRISPR mouse ES cells that had been incubated for 14 h with 10 µM CDKi RO-3306 (Ci), followed by a
further 2-h incubation with nocodazole (30 ng/ml). Cells were harvested at various time points after nocodazole release. fWestern blot for MIDEAS-FLAG
and DNTTIP1 from cell-cycle synchronised cells following co-immunoprecipitation (Co-IP) using a anti-FLAG antibody. Cells synchronised as in
panel e. g Western blot for MIDEAS, DNTTIP1, HDAC2 and HDAC1 from co-IP’s using Rb anti-MIDEAS and Rb anti-DNTTIP1 antibodies. U2OS cells were
blocked for 16 h in the G1/S with aphidicolin (1.6 µg/ml) or M with nocodazole (3.3 µg/ml). A mock IP was also carried out with rabbit IgG as a control.
Antibodies were cross-linked to beads prior to IP. h Fluorescent-based HDAC activity assay of MIDEAS and DNTTIP1 immunoprecipitates from U2OS cells
blocked in the G1/S or M as in panel g. Results are normalised to cell count after detachment from plates (mean ± s.e.m, n= 3 independent experiments,
*P= 0.022, one-way ANOVA with Holm–Sidak post hoc test). Source data are provided as a Source data file.
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sample, and was used as a reference for normalisation (mean ± s.e.m., n= 3 independent experiments, **P= 0.0029, ***P < 0.001 (P= 0.0003 for control
versus DNT_si1, 0.0004 for control versus DNT_si2), ****P < 0.0001, one-way ANOVA with Dunnett’s post hoc test). b Confocal images representative of
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(magenta). DNA (blue) was visualised with Hoechst 33258 (scale bars: 5 μm). c Quantification of metaphase cells with misaligned chromosomes in U2OS
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ANOVA with Holm–Sidak post hoc test). d Quantification of metaphase cells with misaligned chromosomes in HeLa cells after MIDEAS siRNA treatment
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cells with misaligned chromosomes in U2OS cells after siRNA treatment and induction of siRNA-resistant FLAG-DNTTIP1 with DOX (mean ± s.e.m., n= 3
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data are provided as a Source data file.
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was a reduction in the expression of transcripts associated with
mitotic spindle organisation (Supplementary Fig. 5f and Supple-
mentary Table 4). This provides a possible explanation for the
increased misalignment seen in knockout MEFs and siRNA
knockdowns of MIDEAS and DNTTIP1.
The MiDAC dimer complex reveals a distinct mode of
assembly. The finding that MiDAC has a unique functional role
that cannot be compensated for by other HDAC complexes
prompted us to ask whether the assembly of the complex might
also be unique and so sought to determine the structure. We
have shown previously that a complex with full-length HDAC1,
full-length DNTTIP1 and the ELM2-SANT domain from
MIDEAS forms a stable 450-kDa tetramer in solution—a size
suitable for structure determination using cryo-EM26 (Fig. 4a).
We explored a number of conditions to prepare samples of this
complex for cryo-EM. Maps obtained from a grafix cross-linked
tetrameric complex were limited to only around 15-Å resolu-
tion. Gentler cross-linking resulted in a sample that was partly
dissociated during grid preparation, and both dimers and tet-
ramers were observed. By careful masking we were able to
obtain maps of the dimer at ~6-Å resolution, but only 23-Å
resolution for the tetramer (Supplementary Fig. 7). It became
apparent that the DNA-binding domain of DNTTIP1 could not
be observed in maps of either the dimer or tetramer, suggesting
that it is flexibly attached. To overcome this issue, we prepared
a smaller complex lacking the DNA-binding domain of
DNTTIP1 (Fig. 4b). We also included InsP6 and an HDAC
inhibitor (SAHA) since both have previously been shown to
stabilise the HDAC3:SMRT complex27. This smaller complex
was cross-linked on ice and frozen onto UltrAuFoil EM grids.
We collected 2752 micrographs using a Volta Phase Plate on a
Titan Krios G3 with a Falcon III camera (Fig. 4c). As before, we
observed a mixture of dimeric and tetrameric particles and were
able to obtain detailed class averages (Fig. 4d, e). In all, 126,484
particles were included in the final ~4-Å map of the dimeric
complex with C2 symmetry applied (Fig. 5a; Supplementary
Figs. 8 and 9a–c and Supplementary Table 5). For the tetramer,
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63,222 particles were included in the final 4.5-Å map with
D2 symmetry applied (Supplementary Figs. 8 and 9d–f and
Supplementary Table 5). Both the dimer and tetramer grids
suffer from some preferential orientation and map anisotropy
(Supplementary Fig. 9).
The known crystal structures of HDAC13 and the dimerisation
domain of DNTTIP126 could easily be recognised in the maps
and were docked accordingly. The crystal structures of HDAC1
and the dimerisation domain of DNTTIP1 fitted extremely well in
the EM maps and no attempt was made to rebuild the side chains
of these proteins. Models for the MIDEAS co-repressor protein
were obtained using iTASSER and PHYRE based on the
MTA1 structure from the HDAC1:MTA1 crystal structure3,28,29.
MIDEAS was rebuilt into the map taking into account secondary
structure predictions. Rigid body refinement of all three proteins
and one round of simulated annealing were used to optimise the
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Fig. 5 The structure of the dimeric MiDAC complex. a Post-processed cryo-EM map of the dimeric complex from Relion3 with protein chains shown as
cartoons. Map contour level is 0.024—Chimera. b Closeup of the dimerisation domain of DNTTIP1 and a closeup of the dimerisation domain of DNTTIP1
interacting with MIDEAS. Map contour level is 0.024—Chimera. c Cartoon representation of the dimeric MiDAC complex. d Comparison of the MiDAC
complex with the NuRD complex. The active sites are shown with magenta arrows. The dotted magenta arrow indicates that the active site is at the back.
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fit into the map and to remove obvious clashes. Density for the
InsP6, but not the SAHA, was clearly visible in the map
(Supplementary Fig. 10a).
The structure of the dimeric complex has an overall S shape
(Fig. 5a). It reveals that the ELM2 domain from MIDEAS does not
mediate dimerisation. This was unexpected since the homologous
ELM2 domain from MTA1 directly mediates dimerisation in the
NuRD complex3. Instead, the MIDEAS ELM2 domain interacts
with the DNTTIP1 dimerisation domain which mediates the
dimeric assembly (Fig. 5b, c). The consequence of this is that the
HDAC1 catalytic subunits are arranged very differently, located
much farther apart, with the HDAC1 active sites on opposite ends
of the dimer (Fig. 5d). This is a complete contrast with the NuRD
complex in which MTA1 dimerisation results in the HDAC1
active sites being positioned on the same face of the complex
(Fig. 5d).
A structure-based alignment of the ELM2-SANT domains
from MIDEAS and MTA1 reveals the differences that give rise to
the distinct architectures of the two complexes (Fig. 5e). The first
helix of MTA1-ELM2 is significantly longer than the equivalent
helix in MIDEAS. The shorter helix in MIDEAS mediates a tight
interaction with a non-polar groove between the end of the long
helices of the DNTTIP1 dimer (Supplementary Fig. 10b). Other
differences are that MIDEAS lacks helix 2 of the ELM2 domain
which contributes to the homodimer interface in MTA1 (Fig. 5e).
MIDEAS also has an extra helix before the linker leading to the
SANT domain. The SANT domains of MIDEAS and MTA1 are
very similar in structure to each other and to the SANT domain
of the SMRT protein that binds to HDAC32 (Supplementary
Fig. 10c). One of the regions of MIDEAS most similar to other
ELM2-SANT domain co-repressor proteins is the ELM2-specific
motif which binds in an extended conformation in a conserved
groove on HDAC1 (Supplementary Fig. 10c). This interaction
appears to be important for tethering the co-repressor such that it
wraps around the catalytic domain of the HDAC.
MiDAC tetramerization is mediated by both MIDEAS and
DNTTIP1. The final map of the tetrameric particles was refined
using D2 symmetry to ~4.5 Å (Supplementary Figs. 8 and 9). The
DNTTIP1 dimerisation domain and the core of HDAC1 are
somewhat more ordered than other parts of the structure (Sup-
plementary Fig. 9e). The tetrameric complex clearly contains a
dimer of the dimeric complexes with no obvious structural per-
turbations (Fig. 6a, b). The arrangement is such that the
DNTTIP1 dimerisation domains are symmetrically juxtaposed,
but do not directly interact (Fig. 6b; Supplementary Fig. 11). The
two S-shaped dimers are rotated 180° with respect to each other
with the four HDAC subunits positioned at the periphery of the
tetramer, which results in a striking three-dimensional X-shaped
complex (Fig. 6b; Supplementary Fig. 11). This three-dimensional
X-shape of the tetrameric complex positions the active sites of the
four HDACs at the extremities of the complex (Fig. 6c).
The tetramerisation interface between the two dimers is
mediated by interactions between the SANT domains (Fig. 6c).
Residues Lys849, Tyr874 and Val878 contribute to the interface
between the two neighbouring SANT domains (Supplementary
Fig. 10d). These residues are not conserved in MTA1 (Fig. 5e).
Interestingly, Lys839 and Lys843 appear to be in a position to
interact with the inositol phosphate that is bound to the
neighbouring dimer, although there is no apparent density for
the side chains (Supplementary Fig. 10d, e). This may explain
why it was only possible to obtain a high-resolution map of the
tetramer in the presence of inositol phosphate (7.7 Å vs 4.5 Å). A
further obvious effect of the InsP6 was to significantly improve
the local resolution of the core of the HDAC1, consistent with the
proposed mechanism of activation27 (Supplementary Fig. 10f).
In addition to the interactions between the SANT domains it
appears that the residues N-terminal to the DNTTIP1 dimerisa-
tion domain are crossing over to interact with the neighbouring
tetramer. Unfortunately, the quality of the map in this area does
not enable de novo model building (Supplementary Fig. 10g). The
importance of the N-terminal region of DNTTIP1 for tetramer-
isation is supported by biochemical experiments which suggest
that a complex lacking residues 1–49 of DNTTIP1 is no longer
tetrameric based on a size-exclusion column (Supplementary
Fig. 12).
Position of the DNTTIP1 chromatin-binding domain. We also
analysed cryo-EM grids of complexes containing full-length
DNTTIP1, including the DNA-binding domain (Supplementary
Figs. 7 and 12e–g). However, we were only able to achieve low-
resolution (~23 Å) maps with this complex. The overall shape of
the complex (with no symmetry applied) is the same as the
complex without the DBD, but there is additional, ill-defined
density, presumably from the DBD, around the middle of the
complex (Fig. 6d). This suggests that the DBDs are flexibly linked
to the tetrameric core.
Interestingly, when we masked the tetrameric core of the
complex and applied D2 symmetry, we were only able to improve
the resolution to 16 Å (Fig. 6e). It is not clear whether the flexible
DBDs are introducing genuine structural heterogeneity into the
core of the complex or whether the DBDs prevent the processing
algorithms from generating an accurate alignment of the particles.
Flexible attachment of DBDs to the rest of the protein is a
common feature of DNA-binding proteins and is reminiscent of
the DNA-binding domain of the telomere-binding protein TRF1
which can bind to telomeric sequences with widely variable
spacings30. Flexibility would allow the complex to interact with
chromatin in different conformations.
Discussion
HDACs 1 and 2 are assembled into multiple distinct complexes.
Specific proteins in each of these complexes target them to par-
ticular chromatin loci, depending on the role of the particular
complex. Many of the complexes use a conserved ELM2-SANT
domain to mediate interaction with the HDAC catalytic subunit.
The SANT domain creates a binding site for inositol phosphates
at the interface with the HDAC which controls activation of the
enzyme3,27.
In the MiDAC complex, the large ELM2-SANT protein
MIDEAS (1045 aa), recruits HDAC1 or 2. The third component
of the complex is the relatively small protein DNTTIP1 (329 aa)
which contains both a dimerisation domain and DNA-binding
domain26. Our co-immunoprecipitation studies clearly support
an in vivo interaction between the three proteins in the complex.
The proteins also appear to be expressed, co-localise and co-
immunoprecipitate throughout the cell cycle. This is in apparent
contrast to the findings of Bantscheff et al., who showed the
complex was purified on HDAC-inhibitor coupled resin specifi-
cally when cells were blocked in mitosis using nocodazole12. This
could be explained if the active site in the MiDAC complex is
more accessible in cells during mitosis.
siRNA depletion of either MIDEAS or DNTTIP1 suggests
that the MiDAC complex does indeed play a role in cell divi-
sion. In both knockdowns, we observed a significant increase in
chromosome misalignment during mitosis presumably due to
loss of efficient chromosome congression mechanisms. HDAC
complexes have been previously found to be required for nor-
mal mitosis. For example, we have previously observed that
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knockouts of HDAC1 and/or HDAC2 in mouse ES cells results
in lagging chromosomes in the anaphase, formation of micro-
nuclei and monopolar spindles31. It has also been reported that
knockout of HDAC2 in mouse embryos results in misaligned
chromosomes and reduced kinetochore function via increased
H4K16 acetylation during oocyte maturation32. Others have
shown that the HDAC3 NCoR complex localises to the mitotic
spindle and knockdown of HDAC3 resulted in a collapsed
mitotic spindle and chromosome alignment defects33. It was
proposed that this could be the result of increased H3K4
acetylation at centromeres preventing normal di-methylation
and protein recruitment34 or alternatively deacetylation of
nuclear distributed protein C (NuDC), a protein that regulates
mitotic progression35.
Interestingly, siRNA depletion of either MIDEAS or DNTTIP1
resulted in degradation of the other protein, suggesting that the
three-way interaction is obligate. This interdependency is sup-
ported by multiple lines of evidence. First, the mouse deletions
show that the embryos die at the same stage with exactly the same
phenotype. Second, the Cancer Dependency Map shows a strong
co-dependency for DNTTIP1 and MIDEAS (https://depmap.org/
portal/). Finally, the cryo-EM structure of the MiDAC complex
shows that interactions between MIDEAS and DNTTIP1 are
MIDEAS HDAC1DNTTIP1
a
b
c d e
30° 30° 30°
Fig. 6 The structure of the tetrameric MiDAC complex. a Post-processed cryo-EM map of the tetrameric complex from Relion3 with the protein chains
shown as cartoons. The map is coloured according to the protein. Map contour level is 0.015—Chimera. b 30° rotations of the MiDAC tetramer with
enhanced depth-cue. c End-on view of the MiDAC illustrating the interactions between the MIDEAS-SANT domains and InsP6 at the tetramerisation
interface. The InsP6 is shown in green, the HDACs in grey surface and the positions of the HDAC1 active sites are indicated with magenta arrowheads. The
MIDEAS-SANT domains are indicated by white dotted ovals. d Cryo-EM map of the complex with the DNA-binding domain from DNTTIP using
C1 symmetry and no mask. e Cryo-EM map of the complex with the DNA-binding domain from DNTTIP using D2 symmetry and a mask.
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essential to establish the striking tetrameric X-shaped
architecture.
Although DNTTIP1 is unique in the human genome, there are
two genes that encode proteins with significant homology in the
central ELM2-SANT domain of MIDEAS. These are TRERF1
which is expressed in most tissues, and ZNF541, which is expressed
almost exclusively in testes. It is likely that ZNF541 and TRERF1
assemble alternative versions of the complex. Similarly, we have
shown that both HDAC1 and HDAC2 are present in MiDAC
complexes in U2OS cells and are likely to co-exist in the same
complex. This fits with previous proteomic studies which show that
MIDEAS interacts with both HDAC1 and HDAC212–14. Hein et al.
also showed that tagged MIDEAS pulls down the homologous
protein TRERF1 so it is possible that MIDEAS and TRERF1 co-
exist in the same complex14. ZNF541 is not observed in these
proteomic experiments, which is to be expected since its expression
is restricted to the testes.
The near-atomic resolution cryo-EM structure does not
include the DNA-binding domain of DNTTIP1. It also lacks the
N-terminal (716 aa) and C-terminal (158 aa) regions of MIDEAS
that are predicted to be in large part disordered36. The dimer-
isation domain of DNTTIP1 is critical for the assembly of the
complex since it interacts with the ELM2 domain of MIDEAS and
dictates the relative positioning of the HDACs in the dimer. This
dimerisation domain is unique to DNTTIP1 such that to date, no
other proteins in HDAC complexes or elsewhere have been found
to have a similar structure (Pfam name: DNTTIP1_dimer). Tet-
ramerisation of the complex is mediated by the back surface of
the MIDEAS-SANT domain. Interestingly, the tetrameric
arrangement brings the inositol phosphate-binding sites on the
two dimers in close proximity such that two conserved basic
residues in the SANT domain of one MIDEAS are able to interact
across the tetramerisation interface with the inositol phosphate in
the adjacent dimer (Supplementary Fig. 10e). This would suggest
that inositol phosphates may be particularly important for
MiDAC activity.
Whilst the MiDAC complex is unique in having four HDAC
subunits, several other class I HDAC complexes are also multi-
meric. The MTA proteins in the NuRD complex forms a dimeric
architecture with two copies of HDAC1/23,37. Analogously, SDS3
in the Sin3 complex mediates dimerisation assembling two
HDAC1/2 enzymes38. The SMRT/NCoR complex is built round a
tetrameric TBL1 scaffold that again recruits two copies of
HDAC32,11. We suggest that the relative orientation and spacing
of the HDAC active sites is likely to be important for the function
and specificity of these complexes such that the relative orienta-
tions of the multiple HDAC enzymes in the different complexes
might target different conformations of chromatin. Certainly, the
multivalent nature of the MiDAC complex is highly likely to be
important for the efficient and processive deacetylation of chro-
matin domains so as to decommission gene promoters and
enhancers. Given the overall size of the MiDAC complex and the
outward-facing HDAC active sites at the complex extremities, it is
likely that MiDAC is able to simultaneously target multiple
nucleosomes. These distinct features of the MiDAC complex may
be related to the fact that it appears to lack regions that direct
recruitment to specific transcription factors and likely targets
chromatin directly with the DNTTIP1 DNA-binding domain.
Our low-resolution structure of the larger MiDAC complex
containing the DNA-binding domains of DNTTIP1 strongly
suggests that they are flexibly linked to the core complex and are
positioned around the waist of complex. We have previously
shown that the MiDAC complex seems to prefer binding to linker
DNA in chromatin26. It is attractive to imagine that these
domains recruit the complex to open chromatin and that the
flexible linker enables the core tetramer to deacetylate adjacent
nucleosomes or nucleosomes in the local proximity. Such flexibly
attached DNA-binding domains are a common theme in
chromatin-targeted complexes e.g., the telomere-binding
complex30.
To understand the physiological function of MiDAC, we used
CRISPR to create mice lacking either MIDEAS or DNTTIP1.
Importantly, bothMideas−/− and Dnttip1−/− homozygotes die at
the same developmental stage and with identical failure in heart
development and haematopoiesis. These findings are important
since they reveal that the MiDAC complex is essential for life and
the loss cannot be compensated for by other complexes con-
taining class I HDACs. The identical phenotype and gene
expression changes of the two knockouts reinforces the finding
that MIDEAS and DNTTIP1 are mutually interdependent. They
also confirm that the chromosome misalignment phenotype of
the knockdowns in cancer cell lines is due to loss of the MiDAC
complex. Finally, the RNAseq data support the concept that
MiDAC is a gene-regulatory complex, which has not been pre-
viously demonstrated.
The co-dependency of MIDEAS and DNTTIP1 fits well with
the architecture of the complex revealed in the cryo-EM structure.
However, it should be noted that the embryos survive to day e16.5
with many tissues appearing normal. This suggests that the
increased mitotic chromosome misalignment phenotype observed
in cell lines (and MEFs derived from the homozygous embryos) is
not sufficient to perturb normal cell proliferation and differ-
entiation. It is likely therefore that the failure of heart develop-
ment and haematopoiesis is a more specific gene-regulatory
defect. Other class I HDAC complexes have also been shown to
be essential for embryo development including the NuRD,
CoREST, SMRT/NCoR and Sin3 complexes. The cause of death
and the stage at which the embryos die varies depending on the
complex that is deleted, but are generally earlier than the MiDAC
knockouts, suggesting that MiDAC may have a more specialised,
although still essential function39–43. Knockouts of the C. elegans
proteins SAEG-1 and SAEG-2 (orthologues of MIDEAS /
TRERF1 and DNTTIP1, respectively) are not lethal but do cause
defects in body length and other behavioural abnormalities44.
Transcriptomics in MEF cells derived from wild-type and both
Mideas−/− and Dnttip1−/− mutant mice revealed that 468 genes
are perturbed in both knockouts. Strikingly, the direction and
magnitude of the change in RNAs from these overlapping genes
are highly similar in the two knockouts. The majority of the
perturbed genes are upregulated, consistent with the knockout of
a transcriptional repression complex. Many of the perturbed
genes/pathways are key for normal development, explaining the
multiple developmental defects observed. However, the exact
molecular mechanisms underlying these gene expression pertur-
bations remain to be elucidated. Interestingly, Panther analysis
identified a number of cell-cycle-associated genes including
members of the septin family of GTP-binding proteins which
have been implicated in chromosome alignment45. The trend
towards an overall decrease in spindle organising proteins as seen
from GSEA could provide an additional explanation for increased
misalignment in the MIDEAS and DNTTIP1 knockout MEFs.
In conclusion, our structural and functional studies of the
MiDAC complex reveal a striking molecular machine whose
architecture appears to have evolved to facilitate processive
chromatin deacetylation. The complex is clearly important for the
regulation of many developmental genes and is essential for
embryonic development.
Methods
Protein expression in HEK293F cells. The proteins of the MiDAC complex,
DNTTIP1, MIDEAS and HDAC1, were expressed using the pcDNA3 vector in
HEK293F suspension mammalian cells (Invitrogen). For purification of the
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complex, the MIDEAS construct was expressed with an N-terminal 10xHis-
3xFLAG tag and a TEV protease cleavage site. Transient transfections were used to
express the MiDAC complex, which involved mixing 0.1 mg of each plasmid (0.3
mg DNA total) with 30 ml of PBS (Sigma) and then adding 1.2 ml of 0.5 mg/ml PEI
(Sigma). The suspension was vortexed briefly, incubated for 20 min at room
temperature, then added to 300 ml of cells at a density of 1 × 106 cells/ml. The
transfected cultures were harvested 48 h after transfection.
Large-scale purification of the HDAC1/MIDEAS/DNTTIP1 complex. HDAC1/
MIDEAS/DNTTIP1 complexes were purified from 1.2 l of HEK293F cells. After
sonication in a buffer containing 50 mM Tris/Cl pH 7.5, 100 mM potassium
acetate, 10% (v/v) glycerol, 0.5% (v/v) Triton X-100 and Complete EDTA-free
protease inhibitor (Roche) (buffer A), the insoluble material was removed by
centrifugation. The complex was then bound to anti-FLAG resin (Sigma), washed
twice with buffer A; three times with buffer B (50 mM Tris/Cl pH 7.5, 50 mM
potassium acetate, 5% (v/v) glycerol, 0.5 mM TCEP); incubated with 0.5 mg
RNaseA for 1 h at 4 °C and then washed five times with buffer B. TEV protease
was then used to release the MiDAC complex from the resin overnight on a roller
at 4 °C. The complex was gel filtrated on a Superdex-200 column (GE Healthcare)
in 25 mM HEPES pH 7.5, 50 mM potassium acetate, 0.5 mM TCEP before making
EM grids.
Cryo-EM grid preparation. The peak fraction (0.5 ml) from the Superdex-200
column was concentrated to 0.8 mg/ml in a 0.5 ml Amicon Ultra centrifugal filter
with a 10 kDa MWt cutoff. After concentration, the complex was placed on ice. In
total, 50 µM SAHA (an HDAC inhibitor) and 50 µM InsP6 (an HDAC regulator)
were added, followed by an equal volume of 0.25% glutaraldehyde. After 20 min on
ice, the cross-linking was stopped with the addition of Tris/Cl pH 7.5 to 50 mM.
Then 3 µl sample was applied to a 1.2/1.3 UltrAuFoil grid. The grid was blotted for
3 s, before plunge freezing, using a ThermoFisher Vitrobot MKIV at 4 °C and 100%
relative humidity, and storing in liquid nitrogen.
Cryo-EM data collection. Cryo-EM datasets were collected on a ThermoFisher
Titan Krios G3 (EPU 1.9) operated at 300 kV with a Gatan Quantum Energy filter
camera and a Volta Phase Plate with a defocus of −0.5 using a Falcon 3 camera
with a nominal magnification of ×75,000 and a calibrated pixel size of 1.08 Å. A
dose rate of 0.68 electrons per pixel per second in counting mode over 60 s and 75
fractions were used.
Data processing. Relion3.0 was used to process the data46 (Supplementary Figs. 7
and 8). Particles were autopicked after creating references from manually picked
particles. 2D class averaging was used to obtain an initial cleaned particle set. It was
clear at this stage that the particles could be sub-categorised into dimer and tet-
ramer. Further 2D classification was used to split each dataset into dimer and
tetramer particles. After 3D classification, Refine3D, 3D classification without
alignment, Refine3D, particle polishing and CTFrefine, a 4-Å map was obtained for
the dimer and a 4.5-Å map for the tetramer.
Map fitting and refinement. The crystal structures of the HDAC1 and the
dimerisation domain of DNTTIP1 could be unambiguously fitted into the EM
maps for both the dimer and the tetramer using Chimera. An iTASSER model for
the MIDEAS generated based on the crystal structure of the MTA1 in the HDAC1:
MTA1 complex provided a starting point to rebuild the MIDEAS protein. The
MIDEAS model was rebuilt in Coot47 using a sharpened and blurred map gen-
erated using MRCtoMTZ in CCPEM48. In order to facilitate the rebuilding of the
MIDEAS protein, a map masked with the HDAC1 and DNTTIP1 dimerisation
domain was generated. After model rebuilding of the MIDEAS and fitting of the
HDAC1 and DNTTIP1 crystal structures, the model was refined once in Phenix49
using a rigid body refinement followed by one round of simulated annealing to
minimise the clashes. Figures were prepared using either Chimera or MacPymol.
Animals. C57BL/6J mice were maintained in a specified pathogen-free (SPF)
facility and used for mating between 6- and 26-weeks old. Mice were housed in
individually ventilated cages on a 12 h day–night cycle in a temperature (21 ± 2 °C)
and humidity-controlled (55 ± 10%) room. All mice had free access to water and
were fed on the irradiated Teklad rodent diet (Envigo). All animals were kept in
pairs and cages contained bedding made of corn cob with a nestlet (Datesand) and
a cardboard tunnel for environmental enrichment. When breeding, one male was
housed with two females until pregnancy was apparent, either by vaginal plug or an
enlarged abdomen, when the female was separated. As a phenotype for hetero-
zygous and homozygous knockouts was not known, in this study we sought to
determine the viability of such mice using non-invasive genotyping from ear snips
already taken for identification. Mice were culled by an approved technician by
schedule 1 (dislocation of neck followed by cutting the femoral artery). Mouse
embryos were culled by a trained technician by immersion in ice-cold PBS followed
either by decapitation or submersion in fixative.
Generation of CRISPR mice. MIDEAS and DNTTIP1 knockout mice were gen-
erated using CRISPR/Cas9 system50. crRNA (IDT) (20 ng/µl) designed to target
either exon 2 of Mideas (ENSMUSE00000408326: TCCCTACTATAACCACCC
GGAGG) or Dnttip1 (ENSMUSE00000171721: AACATCGGCAGGTGCAGCG
AAGG), 20 ng/µl tracrRNA and 20 ng/µl of Cas9 protein (IDT) were injected into
1-cell C57BL/6J mouse zygotes under standard micro-injection conditions. The
resulting pups were analysed for modified alleles by PCR and then Sanger
sequencing. Mosaic founders were back-crossed to wild-type mice to segregate
alleles, resulting in −10-bp (Mideas) and −11-bp (Dnttip1) deletion mutants.
DNA extraction and genotyping. When only genotyping was required, both mice
and embryos were genotyped from DNA isolated from the ear and tail snips,
respectively, using the HotSHOT method51. Briefly, alkaline lysis buffer (0.07%
NaOH, 0.7 mM EDTA pH 8) was added to tissue samples and incubated at 95 °C
for 30 min followed by 15 min at 4 °C. The lysis buffer was neutralised with an
equal volume of 40 mM Tris-HCl pH 5. For histology, whole embryos were fixed in
10% formalin for 48 h. Before processing and embedding, a tail snip was taken, and
DNA extracted using a previously described method52. Alkali digestion buffer (0.1
M NaOH, 1% SDS, pH 12) was added to tissue samples and incubated at 100 °C for
40 min. The sample was allowed to cool to room temperature before the addition of
25:24:1 phenol:chloroform:isoamyl alcohol. The sample was agitated for 5 min at
room temperature and centrifuged at 10,000 g for 5 min. The upper aqueous layer
was transferred to a new tube with chloroform, agitated for 5 min at room tem-
perature and centrifuged as above. The upper aqueous layer was transferred to a
new tube along with 0.6 volumes isopropanol and 0.1 volume 3M sodium acetate,
pH 5. The solution was mixed briefly before centrifugation at 10,000 g for 30 min at
room temperature. The supernatant was decanted, and the pellet rinsed twice in
85% ethanol with centrifugation at 10,000 g for 5 min between washes. Ethanol was
removed by a brief incubation at 60 °C and the pellet resuspended in 50 µl TE
buffer (10 mM Tris-HCl, pH 8, 0.1 mM EDTA). Isolated DNA was then used for
genotyping by PCR using DreamTaq green PCR master mix (ThermoFisher).
Wild-type and mutant-specific primers for MIDEAS-del1 mice, WT: 318-bp (F: 5′-
CTATAACCACCCGGAGGCAC-3′, R: 5′-GAAGGCAGTTGATGCATGG-3′) or
182-bp mutant (F: 5’-ACCTCCCTACTATAACCACTGA-3′, R: 5’-AAGACCTG
ACGGTTCACCTG-3′); DNTTIP1-del1 mice, WT: 220-bp (F: 5′-AGATCGGCG
GCCCCTTCGCT-3′, R: 5’-GCGAGCTTTGGACATTGGTG-3′) or 351-bp muta-
ted allele (F: 5′-GTCATCTGAGATCGGCGGCA-3′, R: 5′-AGCAATAACCCGAG
CTTGCT-3′) were used. PCR amplification: 35 cycles of 95 °C for 30 s, 60 °C for
30 s and 72 °C for 1 min.
Preparation of embryo sections for histology. Mouse embryos were fixed in 10%
formalin for 48 h before processing using a Leica ASP300 processor. Briefly,
embryos were incubated for 1 h in 10% formalin followed by ×7 1-h incubations
with 99% IMS, ×2 1.5-h incubations with xylene and ×1 1-h and ×2 1.5-h incu-
bations in wax baths. Processed embryos were oriented in metal moulds and
embedded in wax. A microtome cut 4-µm sections of embryos for further staining.
Haematoxylin and eosin staining was automated using a Leica ST4040 Linear
Stainer with a standard protocol. Briefly, sections were washed three times with
xylene followed by a wash with 99% IMS and 95% IMS. After one wash with water,
sections were stained with haematoxylin. After a further three washes with water,
slides were stained with eosin. Sections were then washed in the opposite order to
that described above. Slides were mounted using DPX and imaged using a Leica
M165 or Nikon eclipse TI microscope.
Generation of mouse embryonic fibroblasts (MEFs). Timed mates were set up
as above and females culled by schedule 1 at e13.5. Embryos were removed from
the yolk sacs and washed three times in PBS. Embryo heads, liver and heart were
eviscerated, and the remaining body minced in trypsin. Cells were left for 45 min at
37 °C 5% CO2 before addition of complete DMEM. Cells were pipetted 15 times to
form a single-cell suspension and transferred to a fresh 10-cm dish and cultured
until confluent. MEFs were cultured for up to eight passages before reaching
senescence.
Cell culture. Unless otherwise stated, U2OS osteosarcoma (ATCC, #HTB-96)
and HeLa adenocarcinoma (ATCC, #CCL-2) cells were cultured in DMEM/10%
foetal calf serum (FCS)/1% penicillin/streptomycin (P/S) (complete DMEM). For
RNAi experiments, cells were seeded at 3 × 105 in Opti-MEM®/10% FCS.
Embryonic stem (ES) cell lines were maintained on gelatinised plates in standard
ES cell medium consisting of Knockout DMEM, 15% FCS, 1× glutamine/P/S,
100 µM β-mercaptoethanol and LIF (synthesised in house). Synchronisation was
confirmed by flow cytometry. Cells were blocked by the addition of aphidicolin
(1.6 µg/ml) (G1/S) or nocodazole (3.3 µg/ml) (G2/M) for 16 h and synchronised
using the CDK inhibitor (CDKi; Ci) RO-3306 (10 µM) for 14 h followed by 2 h
with nocodazole (30 ng/ml) before release. For protein expression, 293F cells
were cultured in Freestyle media, as previously described53. All cells were cultured
at 37 °C in a 5% CO2 atmosphere.
Generation of MIDEAS-FLAG in ES cells. CRISPR/Cas9 (sgRNA: GCCCGGCA
ATAGGATCCAGCAGG) was used to modify exon 13 of the mouse Mideas gene
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in E14 embryonic stem (ES) cells. The stop codon was replaced with 3× copies of
the FLAG epitope. Following co-transfection of the sgRNA/Cas9 plasmid (10 µg)
and ssODN (5 µg), 500 cells were plated onto a 10-cm dish, cultured for 10 days,
and the resulting colonies screened for the modified allele using PCR and then
western blotting.
Transient transfection of GFP-MIDEAS and mCherry-DNTTIP1. U2OS (~8 ×
105) were seeded using complete DMEM into six-well plates and allowed to adhere
overnight at 37 °C 5% CO2. Plasmids and lipofectamine® were diluted in Opti-
MEM® and incubated for 5 min at room temperature. The separate solutions were
mixed and incubated for a further 20 min at room temperature before being added
dropwise to the U2OS cells. Cells were incubated at 37 °C for 48 h in 5% CO2 to
allow for protein expression. Cells were then fixed for immunofluorescence or lysed
directly with SDS sample buffer prior to western blotting.
Oligonucleotides used to generate GFP-MIDEAS and mCherry-DNTTIP1
constructs are provided in Supplementary Table 6.
Generation of FLAG-DNTTIP1 stable cell line. To generate a stable doxycycline
(DOX) inducible siRNA-resistant FLAG-DNTTIP1 U2OS cell line, primers were
designed to incorporate two silent mutations in the siRNA target sequences
directed against DNTTIP1. These were introduced sequentially using PCR. A full-
length DNTTIP1 PCR product with an N-terminal FLAG tag incorporating
mutations in both sequences was cloned into a PiggyBac vector that contained a
puromycin selection gene. The PiggyBac vector and a vector encoding transposase
(Systems Bioscience, #PB210PA-1) were transiently transfected into U2OS cells
using lipofectamine®. After 24 h, 80,000 cells were seeded into a 10-cm dish and
grown in complete DMEM with 0.8 µg/ml puromycin. A minimum of 12 indivi-
dual colonies were expanded and induced for 24 h with 1 μg/ml DOX. FLAG
expression was tested by western blotting.
Oligonucleotide’s used to generate DNTTIP1 siRNA-resistant DOX inducible
U2OS cell line are provided in Supplementary Table 6.
Knockdown of MIDEAS and DNTTIP1 using siRNA. Two siRNAs directed
against either MIDEAS or DNTTIP1 (see below) were transfected into cells using
OligofectamineTM reagent. Briefly, in separate tubes, individual siRNA or Oligo-
fectamineTM was diluted in Opti-MEM® and incubated at room temperature for
5 min. The siRNA/Opti-MEM® mixture was added to the OligofectamineTM and
incubated at room temperature for a further 20 min. Cells that had been seeded the
day before in Opti-MEM® 10% FCS were transferred to just Opti-MEM®, and the
transfection mixture was added dropwise. After incubation for 6 h, Opti-MEM®
with 30% FCS was added and the cells incubated for a further 72 h to achieve
knockdown.
siRNA sequences and sources used in this study:
● MID_si1–5′-UCUGAAGAGAAGCGGAAAA-3′ (DharmaconTM, #J-031938-
19)
● MID_si2–5′-AAACAGAGACAUUCAGUAAtt-3′ (Ambion®, #s40760)
● DNT_si1–5′-CCCACACCUCUUUAAGUAUtt-3′ (Ambion®, #s41923)
● DNT_si2–5′-CCUUGGAACAUAAUGAUAAtt-3′ (Ambion®, #s41294).
Real-time qPCR. For relative mRNA expression by qPCR, RNA was purified from
cells using the quick RNA mini prep kit (Zymo Research). Briefly, cells were lysed
in lysis buffer, cleared by centrifugation and gDNA removed using a spin-awayTM
filter. An equal volume of 100% ethanol was added to the flow through and
transferred to a Zymo-SpinTM IIICG column. The RNA was bound to the column,
washed once with RNA wash buffer and the membrane incubated with DNase 1 for
15 min. The column was washed once with RNA prep buffer followed by two
washes with RNA wash buffer before elution with 100 µl DNase/RNase-free water.
The concentration and quality of the RNA were analysed using a nanodrop. cDNA
was synthesised from 1 µg of the total RNA using 5× qScript reaction mixture and
qScript reverse transcriptase (Quanta Bioscience). cDNA was synthesised using the
following programme: 22 °C, 5 min; 42 °C, 30 min; 85 °C 5 min; 4 °C. cDNA was
diluted 1 in 5 and stored at −20 °C. Real-time qPCR was carried out using the
SensiFASTTM kit (Bioline) with 400 nM forward and reverse primer and 2 µl
cDNA. In this study, primers for human MIDEAS (Qiagen; QT00076160),
DNTTIP1 (Qiagen; QT00069664), HDAC1 (Qiagen; QT00015239) and the
housekeeping gene β2-microglobulin (Qiagen; QT00088935) were used and PCR
product amplified with 35 cycles of 95 °C for 10 s, 60 °C for 30 s and 72 °C for 1
min using a CFX ConnectTM real-time system (Bio-Rad).
Cell-cycle analysis. To determine cell-cycle distribution, cells were washed once
with PBS before fixation with −20 °C 70% (v/v) ethanol at 4 °C for 30 min. Cells
were washed two times with PBS and incubated with 50 μg propidium iodide (PI)
and RNaseA (10 μg/ml, thermoFisher) for 16 h at 4 °C. Samples were analysed
using a BD AccuriTM C6 flow cytometer (BD Biosciences) and FCSalyzer software
v0.9.15-alpha. Gating strategies used for each cell type are shown in Supplementary
Fig. 13.
Immunofluorescence microscopy. Cells were grown on acid-treated coverslips
and fixed with −20 °C methanol or 4% paraformaldehyde (PFA) followed by
permeabilisation with 0.2% Triton X-100/PBS. Following fixation/permeabilisation,
cells were washed three times in PBS and blocked with 2% BSA/PBS for 30 min. All
subsequent antibody incubations were carried out in PBS with 3% BSA. Primary
antibodies used in this study were rabbit anti-MIDEAS (1:50; Atlas #HPA003111),
rabbit anti-DNTTIP1 (1:100; Abcam #ab174663), rabbit anti-HDAC1 (1:200;
Abcam #ab109411), anti-α-tubulin (rabbit: 1:1000, ThermoFisher #PA5-19489;
mouse: 1:2000, Sigma #T9026) and mouse anti-cenpA (1:1000; Abcam #ab13939).
Cells were dual stained for 1.5 h and then washed three time with PBS. Primary
antibodies were detected with goat anti-rabbit 488 and goat anti-mouse 594 anti-
bodies (1:200; Invitrogen #A32731 #A32742, respectively). DNA was stained with
Hoechst 33258 (0.2 μg/ml). After two final washes in PBS followed by two washes
in dH2O, coverslips were mounted in 80% glycerol, 3% n-propylgalate mounting
medium. Cells were imaged using a Leica SP5 laser-scanning confocal microscope
with the 63x oil immersion lens. Chromosome misalignment was defined when
microtubules were perpendicular to condensed chromosomes with co-localisation
of DNA and cenpA outside the microtubule region.
Isolation of cytosolic and nuclear proteins. Cytosolic, soluble nuclear and
insoluble nuclear proteins were isolated using a commercial kit (Abcam
#ab219177) following the manufacturer’s instructions. Briefly, cells were washed
once in ice-cold PBS and lysed with cytosolic extraction buffer. After incubation on
ice, nuclei were pelleted by centrifugation at 1000 g for 3 min at 4 °C, and cytosolic
proteins transferred to a clean microfuge tube. Nuclei were lysed using soluble
nuclear lysis buffer and the suspension incubated on ice for 15 min, vortexing every
5 min. Insoluble material was pelleted by centrifugation at 5000 g for 3 min at 4 °C,
and the soluble nuclear fraction transferred to a clean microfuge tube. Insoluble
nuclear lysis buffer was added to the DNA:protein pellet and disrupted by
intermittent sonication (10 s on, 10 s off). Isolated protein fractions were stored at
−80 °C. Each buffer was supplemented with 200× protease inhibitor cocktail and
DTT supplied with the kit.
Immunoprecipitation. Protein A or G Dynabeads® (1.2 mg; Life Technologies)
were washed with lysis buffer and incubated with primary antibodies for 30 min at
4 °C. In this study, primary antibodies used were rabbit anti-MIDEAS (Atlas),
rabbit anti-DNTTIP1 (Abcam), a rabbit polyclonal IgG control (Abcam #ab37415),
mouse anti-FLAG (Sigma #F3165) and a mouse monoclonal IgG control (Santa
Cruz #sc-2025) (all 1 μg). In some cases, IgG or antibody was covalently coupled to
Dynabeads® using BS3 (ThermoFisher #A39266). Antibody-coupled Dynabeads®
were washed once with conjugation buffer (20 mM sodium phosphate, 0.15M
NaCl, pH 8) and suspended in conjugation buffer with 5 mM BS3. The antibody/
Dynabeads® suspension was rotated for 30 min at room temperature and cross-
linking quenched by addition of 1/20 volume 1M Tris/HCl, pH 7.5 and rotation
for 15 min at room temperature. The cross-linked Dynabeads®/antibodies were
washed three times in lysis buffer before proceeding with the IP. Protein lysates
were added to the antibody-coupled Dynabeads® and incubated at 4 °C for 16 h
with gentle mixing. Immunoprecipitates were washed three times in lysis buffer
and re-suspended in an appropriate amount of buffer for downstream applications.
SDS-PAGE and western blotting. Separation and detection of proteins by SDS-
PAGE and western blotting was carried out using NuPAGE 4-12% Bis-Tris gels
(Invitrogen) and a semi-dry transfer system using nitrocellulose membranes.
Membranes were blocked for 1 h at room temperature using 5% milk TBS/T and
incubated in primary antibody diluted in blocking buffer overnight at 4 °C. For
western blotting, antibodies used were rabbit anti-MIDEAS (1:300, Atlas), rabbit
anti-DNTTIP1 (1:500, Abcam), anti-HDAC1 (rabbit: 1:500, Abcam; mouse: 1:400,
Santa Cruz), mouse anti-HDAC2 (1:1000, Sigma, #05-814), mouse anti-FLAG
(1:2000, Sigma), goat anti-LaminB (1:1000, Santa Cruz) and rabbit anti-α-tubulin
(1:1000, ThermoFisher). Goat anti-mouse HRP (1:2000, #12-349), goat anti-rabbit
HRP (1:2000, #12-348), donkey anti-goat HRP (1:5000, #AP180P) (all from
Sigma), goat anti-rabbit 800CW (1:10000, #925-32211) and goat anti-mouse
680RD (1:10,000, #925-68070) (both from Li-COR, IRDye®) secondary antibodies
were incubated with membranes for 1 h at room temperature and detected using
either enhanced chemiluminescence (ThermoFisher) or an Odyssey CLx digital
imaging system (LI-COR).
Histone deacetylase activity assay. HDAC activity was measured using Boc-Lys
(Ac)-AMC substrate (BaChem #4033972). Immunoprecipitated complexes were
left bound to the Dynabeads® without cross-linking of antibodies. In some cases,
immunoprecipitates were pre-incubated in the presence or absence of either InsP6
(100 μM) or SAHA (5 μM) for 30 min at room temperature with gentle agitation.
Immunoprecipitates and Boc-Lys(Ac)-AMC substrate (500 µM final concentra-
tion) were used in a final volume of 50 µl in lysis buffer. After incubation at 37 °C
for 30 min and 200 rpm, the assay was developed with the addition of 50 µl of
developer solution (50 mM Tris/HCl pH 7.5, 100 mM NaCl, 2 mM Trichostatin A,
10 mg/ml Trypsin). Fluorescence was measured at 335/460 using a Victor X5 plate
reader (Perkin Elmer). Technical duplicates were performed a minimum of three
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times, and the data were analysed using GraphPad Prism (version 7.0, GraphPad
Software, Inc.).
Generation and analysis of RNAseq data. RNAseq data were collected using
total RNA from wild-type and knockout MIDEAS and DNTTIP1 cell lines.
Briefly, the total RNA was extracted from MEF cells using the quick RNA mini
prep kit (described above), quality checked using a bioanalyzer and shipped at 2
µg on dry ice to Novagene (China). Samples were enriched for mRNA before
double-strand cDNA synthesis. Adaptor sequences, containing an overhang,
were ligated to the cDNA. After fragmentation, the library was quality
tested before Illumina sequencing. Each sample was read to a depth of 20 × 106
reads. The data files were processed in house. Adaptor sequences were trimmed
using the Trim Galore! wrapper for Cutadapt, with the default settings.
Sequences shorter than 35 bp were removed. The trimmed reads were then
aligned to the most recent Mus musculus genome (MM10), using the STAR
aligner with the default settings. Transcripts were deduplicated, with Picard,
sorted and indexed (SAMtools) before analysis using DESEQ2 software in R to
generate principle component plots for the data. Comparisons of gene expres-
sion differences were carried out between wild-type samples and the MIDEAS
and DNTTIP1 knockout samples. Differences were deemed significant with a
P-value of <0.1.
Study approval. All animal experiments conformed to the British Home Office
Regulations (Animals (Scientific Procedures) Act 1986). The project was approved
by the Animal Welfare and Ethical Review Board (AWERB) at the University of
Leicester under Project licence P16D64BDE (Dr Amanda Pickard) and
PEBDF7FCB (Prof Shaun Cowley) following the principles of the 3Rs and ARRIVE
guidelines.
Statistical analysis. All data graphs are presented as mean ± SEM, and accom-
panying statistics were generated using GraphPad Prism software. Statistical tests
and replicate number for each individual experiment is stated in the accompanying
figure legend.
Materials availability. Unique reagents generated in this study are available from
the lead contact with a completed Materials Transfer Agreement.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The EM maps for the dimer and tetramer are available from EMDB under the accession
codes EMD-11041 and EMD-11042. The coordinates for the dimer and tetramer models
are available from the PDB under the accession codes 6Z2J and 6Z2K. The RNAseq data
that support the findings of this study have been deposited in GEO with the primary
accession code GSE144748. The source data underlying Figs. 1–3 and Supplementary
Figs. 1, 3, 4, 5, 6, 9 and 12 are provided as a Source Data file. All other data are available
from the corresponding authors on reasonable request.
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